@Bubbadog @krakensos $MRNY won't hit $10 unless there's another pandemic scare, a reverse split, or a major new cancer drug approval. These YieldMax products do well in sideways markets, which is where $MRNA has been since April after a big drop and is now recovering. It'll likely be cheap again soon with a new ATL from the ex-div date but might stay in the same range unless the market corrects. I'm in it just for the trade, hoping to snag some free shares by closing it out later.
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
